Curtin, Karen , PhD, MStat

Research Interests

  • Gene-Environment Interaction
  • Cancer Epidemiology with Emphasis on Colorectal Cancer
  • Environmental Pollution
  • Epigenetics in Cancer
  • Age-related macular degeneration and co-segregating diseases

Languages

  • English
  • Modern Greek (1453-)
  • Spanish

Academic Information

  • Departments: Internal Medicine - Research Associate Professor, Ophthalmology/Visual Sciences - Adjunct Associate Professor
  • Divisions: Epidemiology
  • Cancer Center Programs: Cancer Control & Population Sciences

Academic Office Information

  • 801-585-5320
  • Pedigree and Population Resource
    Utah Population Database, University of Utah & Huntsman Cancer Institute
    675 Arapeen Drive, Room: 210 (Suite 200)
    Salt Lake City, UT 84112

Academic Bio

Karen Curtin (PhD, MStat) is an associate research professor in the Department of Medicine (Division of Genetic Epidemiology) and an adjunct associate professor in the Department of Ophthalmology and Visual Sciences at the University of Utah School of Medicine and the John A. Moran Eye Center, Sharon Eccles Steele Center for Translational Medicine. She serves as Associate Director of Pedigree & Population Resource at the Huntsman Cancer Institute, the group that administers the Utah Population Database (the UPDB). In this capacity, she collaborates as a genetic and risk factor epidemiologist with investigators across the Health Sciences Center in addition to pursuing her own research interests. Dr. Curtin is a Huntsman Cancer Institute investigator and member of the Cancer Control and Population Sciences program, with a keen interest in the interaction of environmental, lifestyle, and genetic risk factors in the development of common, complex disease using unique research resources available in the state of Utah.

Her wide array of research interests and experience in research infrastructure and project development have resulted in cross-disciplinary collaborations that include an investigation partnering with the College of Pharmacy and Intermountain Healthcare clinicians to investigate a statewide cohort of amphetamine-type stimulant users to examine the incidence of Parkinson's disease. She is undertaking a study to use electronic databases to identify a subset of colorectal adenomas (sessile serrated polyps), of which little is known at the population level. It is thought these lesions are associated with missed or ‘interval’ cancers, but studies to date have been small, clinic-based investigations. She is currently funded to investigate novel areas of mammographic breast density in relation to breast cancer, the familiality breast density in a large Utah cohort of women and the association of tamoxifen treatment with breast density and breast cancer recurrence and metastatic progression. The research directly relates to cancer prevention by potentially informing screening recommendations and may provide further evidence of the role of genetics in breast density, a known risk factor for breast cancer and will utilize UPDB information linked to University and Intermountain records including complex radiology and pharmacy data.

Curtin received her PhD in biomedical informatics with an emphasis in genetic epidemiology from the University of Utah. She received post-doctoral training in molecular, genetic, and risk factor epidemiology of cancer at the University of Utah. Prior to receiving her PhD, she was a Masters level biostatistician on large externally-funded cancer studies. She received the 2008 John D. Morgan Fellowship Award in Biomedical Informatics at the University of Utah. A prolific and extensively published researcher, she recently received recognition from Cancer Epidemiology, Biomarkers & Prevention, a high-impact peer-reviewed journal, for one of the 20 most frequently cited articles of 2009. Dr. Curtin is a member of the American Society of Human Genetics, the American Association for Cancer Research and the International Genetic Epidemiology Society.

Education History

Type School Degree
Doctoral Training University of Utah School of Medicine, Clinical and Translational Track: Genetic Epidemiology
Biomedical Informatics
Ph.D.
Graduate Training University of Utah, College of Social and Behavioral Sciences
Econometrics and Statistics
M.Stat
Undergraduate University of Utah, College of Business
Economics, Magna Cum Laude
B.S.

Selected Publications

Journal Article

  1. Wu YP, Kohlmann W, Curtin K, Yu Z, Hanson HA, Hashibe M, Parsons BG, Wong J, Schiffman JD, Grossman D, Leachman SA (2018 Feb). Melanoma risk assessment based on relatives' age at diagnosis. Cancer Causes Control, 29(2), 193-199.
  2. Waller RG, Darlington TM, Wei X, Madsen MJ, Thomas A, Curtin K, Coon H, Rajamanickam V, Musinsky J, Jayabalan D, Atanackovic D, Rajkumar SV, Kumar S, Slager S, Middha M, Galia P, Demangel D, Salama M, Joseph V, McKay J, Offit K, Klein RJ, Lipkin SM, Dumontet C, Vachon CM, Camp NJ (2018 Feb). Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk. PLoS Genet, 14(2), e1007111.
  3. Wei X, Calvo-Vidal MN, Chen S, Wu G, Revuelta MV, Sun J, Zhang J, Walsh MF, Nichols KE, Joseph V, Snyder C, Vachon CM, McKay JD, Wang SP, Jayabalan DS, Jacobs LM, Becirovic D, Waller RG, Artomov M, Viale A, Patel J, Phillip JM, Chen-Kiang S, Curtin K, Salama M, Atanackovic D, Niesvizky R, Landgren O, Slager SL, Godley LA, Churpek J, Garber JE, Anderson KC, Daly MJ, Roeder RG, Dumontet C, Lynch HT, Mullighan CG, Camp NJ, Offit K, Klein RJ, Yu H, Cerchietti L, Lipkin SM (2018 Mar 20). Germline mutations in lysine specific demethylase 1 (LSD1/KDM1A) confer susceptibility to multiple myeloma.LID - canres.1900.2017 [pii]LID - 10.1158/0008-5472.CAN-17-1900 [doi]. (Epub ahead of print) Cancer Res.
  4. Kleinstern G, Camp NJ, Goldin LR, Vachon CM, Vajdic CM, de Sanjose S, Weinberg JB, Benavente Y, Casabonne D, Liebow M, Nieters A, Hjalgrim H, Melbye M, Glimelius B, Adami HO, Boffetta P, Brennan P, Maynadie M, McKay J, Cocco PL, Shanafelt TD, Call TG, Norman A, Hanson C, Robinson D, Chaffee KG, Brooks-Wilson AR, Monnereau A, Clavel J, Glenn M, Curtin K, Conde L, Bracci PM, Morton LM, Cozen W, Severson RK, Chanock SJ, Spinelli JJ, Johnston JB, Rothman N, Skibola CF, Leis JF, Kay NE, Smedby KE, Berndt SI, Cerhan JR, Caporaso N, Slager SL (2018 Apr 19). Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.LID - blood-2017-11-814608 [pii]LID - 10.1182/blood-2017-11-814608 [doi]. (Epub ahead of print) Blood.
  5. Samadder NJ, Wong J, Curtin K (2018 Apr 19). Misclassification of Upper Tract Urothelial Carcinoma in Patients With Lynch Syndrome-Reply.LID - 10.1001/jamaoncol.2018.0545 [doi]. (Epub ahead of print) JAMA Oncol.
  6. Wang SS, Carrington M, Berndt SI, Slager SL, Bracci PM, Voutsinas J, Cerhan JR, Ekstrom Smedby K, Hjalgrim H, Vijai J, Morton LM, Vermeulen R, Paltiel O, Vajdic CM, Linet MS, Nieters A, de Sanjose S, Cozen W, Brown EE, Turner J, Spinelli JJ, Zheng T, Birmann BM, Flowers CR, Becker N, Holly EA, Kane E, Weisenburger D, Maynadie M, Cocco P, Albanes D, Weinstein SJ, Teras LR, Diver WR, Lax SJ, Travis RC, Kaaks R, Riboli E, Benavente Y, Brennan P, McKay JD, Delfau-Larue MH, Link BK, Magnani C, Ennas MG, Latte G, Feldman AL, Wong Doo N, Giles GG, Southey MC, Milne RL, Offit K, Muskinsky J, Arslan AA, Purdue MP, Adami HO, Melbye M, Glimelius B, Conde L, Camp NJ, Glenn M, Curtin K, Clavel J, Monnereau A, Cox DG, Ghesquieres H, Salles G, Boffetta P, Foretova L, Staines A, Davis S, Severson RK, Lan Q, Brooks-Wilson A, Smith MT, Roman E, Kricker A, Zhang Y, Kraft P, Chanock SJ, Rothman N, Hartge P, Skibola CF (2018 May 7). HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes.LID - canres.2900.2017 [pii]LID - 10.1158/0008-5472.CAN-17-2900 [doi]. (Epub ahead of print) Cancer Res.
  7. Samadder NJ, Pappas L, Boucherr KM, Smith KR, Hanson H, Fraser A, Wan Y, Burt RW, Curtin K (2017 Sep). Long-Term Colorectal Cancer Incidence After Negative Colonoscopy in the State of Utah: The Effect of Family History. Am J Gastroenterol, 112(9), 1439-1447.
  8. Samadder NJ, Smith KR, Wong J, Thomas A, Hanson H, Boucher K, Kopituch C, Cannon-Albright LA, Burt RW, Curtin K (2017 Dec 1). Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome. JAMA Oncol, 3(12), 1697-1701.
  9. Padia R, Alt JA, Curtin K, Muntz HR, Orlandi RR, Berger J, Meier JD (2017 Oct). Environmental contributions to otitis media requiring tympanostomy tubes. Int J Pediatr Otorhinolaryngol, 101, 97-101.
  10. Aung T, Ozaki M, Lee MC, Schlotzer-Schrehardt U, Thorleifsson G, Mizoguchi T, Igo RP Jr, Haripriya A, Williams SE, Astakhov YS, Orr AC, Burdon KP, Nakano S, Mori K, Abu-Amero K, Hauser M, Li Z, Prakadeeswari G, Bailey JNC, Cherecheanu AP, Kang JH, Nelson S, Hayashi K, Manabe SI, Kazama S, Zarnowski T, Inoue K, Irkec M, Coca-Prados M, Sugiyama K, Jarvela I, Schlottmann P, Lerner SF, Lamari H, Nilgun Y, Bikbov M, Park KH, Cha SC, Yamashiro K, Zenteno JC, Jonas JB, Kumar RS, Perera SA, Chan ASY, Kobakhidze N, George R, Vijaya L, Do T, Edward DP, de Juan Marcos L, Pakravan M, Moghimi S, Ideta R, Bach-Holm D, Kappelgaard P, Wirostko B, Thomas S, Gaston D, Bedard K, Greer WL, Yang Z, Chen X, Huang L, Sang J, Jia H, Jia L, Qiao C, Zhang H, Liu X, Zhao B, Wang YX, Xu L, Leruez S, Reynier P, Chichua G, Tabagari S, Uebe S, Zenkel M, Berner D, Mossbock G, Weisschuh N, Hoja U, Welge-Luessen UC, Mardin C, Founti P, Chatzikyriakidou A, Pappas T, Anastasopoulos E, Lambropoulos A, Ghosh A, Shetty R, Porporato N, Saravanan V, Venkatesh R, Shivkumar C, Kalpana N, Sarangapani S, Kanavi MR, Beni AN, Yazdani S, Lashay A, Naderifar H, Khatibi N, Fea A, Lavia C, Dallorto L, Rolle T, Frezzotti P, Paoli D, Salvi E, Manunta P, Mori Y, Miyata K, Higashide T, Chihara E, Ishiko S, Yoshida A, Yanagi M, Kiuchi Y, Ohashi T, Sakurai T, Sugimoto T, Chuman H, Aihara M, Inatani M, Miyake M, Gotoh N, Matsuda F, Yoshimura N, Ikeda Y, Ueno M, Sotozono C, Jeoung JW, Sagong M, Park KH, Ahn J, Cruz-Aguilar M, Ezzouhairi SM, Rafei A, Chong YF, Ng XY, Goh SR, Chen Y, Yong VHK, Khan MI, Olawoye OO, Ashaye AO, Ugbede I, Onakoya A, Kizor-Akaraiwe N, Teekhasaenee C, Suwan Y, Supakontanasan W, Okeke S, Uche NJ, Asimadu I, Ayub H, Akhtar F, Kosior-Jarecka E, Lukasik U, Lischinsky I, Castro V, Grossmann RP, Megevand GS, Roy S, Dervan E, Silke E, Rao A, Sahay P, Fornero P, Cuello O, Sivori D, Zompa T, Mills RA, Souzeau E, Mitchell P, Wang JJ, Hewitt AW, Coote M, Crowston JG, Astakhov SY, Akopov EL, Emelyanov A, Vysochinskaya V, Kazakbaeva G, Fayzrakhmanov R, Al-Obeidan SA, Owaidhah O, Aljasim LA, Chowbay B, Foo JN, Soh RQ, Sim KS, Xie Z, Cheong AWO, Mok SQ, Soo HM, Chen XY, Peh SQ, Heng KK, Husain R, Ho SL, Hillmer AM, Cheng CY, Escudero-Dominguez FA, Gonzalez-Sarmiento R, Martinon-Torres F, Salas A, Pathanapitoon K, Hansapinyo L, Wanichwecharugruang B, Kitnarong N, Sakuntabhai A, Nguyn HX, Nguyn GTT, Nguyn TV, Zenz W, Binder A, Klobassa DS, Hibberd ML, Davila S, Herms S, Nothen MM, Moebus S, Rautenbach RM, Ziskind A, Carmichael TR, Ramsay M, Alvarez L, Garcia M, Gonzalez-Iglesias H, Rodriguez-Calvo PP, Cueto LF, Oguz C, Tamcelik N, Atalay E, Batu B, Aktas D, Kasim B, Wilson MR, Coleman AL, Liu Y, Challa P, Herndon L, Kuchtey RW, Kuchtey J, Curtin K, Chaya CJ, Crandall A, Zangwill LM, Wong TY, Nakano M, Kinoshita S, den Hollander AI, Vesti E, Fingert JH, Lee RK, Sit AJ, Shingleton BJ, Wang N, Cusi D, Qamar R, Kraft P, Pericak-Vance MA, Raychaudhuri S, Heegaard S, Kivela T, Reis A, Kruse FE, Weinreb RN, Pasquale LR, Haines JL, Thorsteinsdottir U, Jonasson F, Allingham RR, Milea D, Ritch R, Kubota T, Tashiro K, Vithana EN, Micheal S, Topouzis F, Craig JE, Dubina M, Sundaresan P, Stefansson K, Wiggs JL, Pasutto F, Khor CC (2017 May 29). Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci.LID - 10.1038/ng.3875 [doi]. (Epub ahead of print) Nat Genet.
  11. Anderson MB, Curtin K, Wong J, Pelt CE, Peters CL, Gililland JM (2017 Jun 07). Familial Clustering Identified in Periprosthetic Joint Infection Following Primary Total Joint Arthroplasty: A Population-Based Cohort Study. J Bone Joint Surg Am, 99(11), 905-913.
  12. Law PJ, Berndt SI, Speedy HE, Camp NJ, Sava GP, Skibola CF, Holroyd A, Joseph V, Sunter NJ, Nieters A, Bea S, Monnereau A, Martin-Garcia D, Goldin LR, Clot G, Teras LR, Quintela I, Birmann BM, Jayne S, Cozen W, Majid A, Smedby KE, Lan Q, Dearden C, Brooks-Wilson AR, Hall AG, Purdue MP, Mainou-Fowler T, Vajdic CM, Jackson GH, Cocco P, Marr H, Zhang Y, Zheng T, Giles GG, Lawrence C, Call TG, Liebow M, Melbye M, Glimelius B, Mansouri L, Glenn M, Curtin K, Diver WR, Link BK, Conde L, Bracci PM, Holly EA, Jackson RD, Tinker LF, Benavente Y, Boffetta P, Brennan P, Maynadie M, McKay J, Albanes D, Weinstein S, Wang Z, Caporaso NE, Morton LM, Severson RK, Riboli E, Vineis P, Vermeulen RC, Southey MC, Milne RL, Clavel J, Topka S, Spinelli JJ, Kraft P, Ennas MG, Summerfield G, Ferri GM, Harris RJ, Miligi L, Pettitt AR, North KE, Allsup DJ, Fraumeni JF, Bailey JR, Offit K, Pratt G, Hjalgrim H, Pepper C, Chanock SJ, Fegan C, Rosenquist R, de Sanjose S, Carracedo A, Dyer MJ, Catovsky D, Campo E, Cerhan JR, Allan JM, Rothman N, Houlston R, Slager S (2017 Feb 06). Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nat Commun, 8, 14175.
  13. Alt JA, Thomas AJ, Curtin K, Wong J, Rudmik L, Orlandi RR (2017 Mar 08). Mortality risk in patients with chronic rhinosinusitis and its association to asthma.LID - 10.1002/alr.21931 [doi]. (Epub ahead of print) Int Forum Allergy Rhinol.
  14. Affolter K, Gligorich K, Samadder NJ, Samowitz WS, Curtin K (2017 Mar 17). Feasibility of Large-Scale Identification of Sessile Serrated Polyp Patients Using Electronic Records: A Utah Study.LID - 10.1007/s10620-017-4543-9 [doi]. (Epub ahead of print) Dig Dis Sci.
  15. Jewel Samadder N, Valentine JF, Guthery S, Singh H, Bernstein CN, Wan Y, Wong J, Boucher K, Pappas L, Rowe K, Bronner M, Ulrich CM, Burt RW, Curtin K, Smith KR (2017 Jan 03). Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.LID - 10.1007/s10620-016-4435-4 [doi]. (Epub ahead of print) Dig Dis Sci.
  16. Wirostko BM, Curtin K, Ritch R, Thomas S, Allen-Brady K, Smith KR, Hageman GS, Allingham RR (2016 Nov 01). Risk for Exfoliation Syndrome in Women With Pelvic Organ Prolapse : A Utah Project on Exfoliation Syndrome (UPEXS) Study. JAMA Ophthalmol, 134(11), 1255-1262.
  17. Rand KA, Song C, Dean E, Serie DJ, Curtin K, Sheng X, Hu D, Huff CA, Bernal-Mizrachi L, Tomasson MH, Ailawadhi S, Singhal S, Pawlish K, Peters ES, Bock CH, Stram A, Van Den Berg DJ, Edlund CK, Conti DV, Zimmerman T, Hwang AE, Huntsman S, Graff J, Nooka A, Kong Y, Pregja SL, Berndt SI, Blot WJ, Carpten J, Casey G, Chu L, Diver WR, Stevens VL, Lieber MR, Goodman PJ, Hennis AJ, Hsing AW, Mehta J, Kittles RA, Kolb S, Klein EA, Leske C, Murphy AB, Nemesure B, Neslund-Dudas C, Strom SS, Vij R, Rybicki BA, Stanford JL, Signorello LB, Witte JS, Ambrosone CB, Bhatti P, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ, Ziegler RG, Nyante SJ, Bandera EV, Birmann BM, Ingles SA, Press MF, Atanackovic D, Glenn MJ, Cannon-Albright LA, Jones B, Tricot G, Martin TG, Kumar SK, Wolf JL, Deming Halverson SL, Rothman N, Brooks-Wilson AR, Rajkumar SV, Kolonel LN, Chanock SJ, Slager SL, Severson RK, Janakiraman N, Terebelo HR, Brown EE, De Roos AJ, Mohrbacher AF, Colditz GA, Giles GG, Spinelli JJ, Chiu BC, Munshi NC, Anderson KC, Levy J, Zonder JA, Orlowski RZ, Lonial S, Camp NJ, Vachon CM, Ziv E, Stram DO, Hazelett DJ, Haiman CA, Cozen W (2016 Dec). A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. Cancer Epidemiol Biomarkers Prev, 25(12), 1609-1618.
  18. Samadder NJ, Smith KR, Wong J, Hanson H, Boucher K, Burt RW, Charlton M, Byrne KR, Gallegos-Orozco JF, Koptiuch C, Curtin K (2016 Dec). Familial Risk of Biliary Tract Cancers: A Population-Based Study in Utah. Dig Dis Sci, 61(12), 3627-3632.
  19. Padia R, Alt JA, Curtin K, Muntz HR, Orlandi RR, Berger J, Meier JD (2016 Nov 11). Familial link of otitis media requiring tympanostomy tubes.LID - 10.1002/lary.26360 [doi]. (Epub ahead of print) Laryngoscope.
  20. Neklason DW, VanDerslice J, Curtin K, Cannon-Albright LA (2016 Feb). Evidence for a heritable contribution to neuroendocrine tumors of the small intestine. Endocr Relat Cancer, 23(2), 93-100.
  21. Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Akerley W, Gilcrease G, Ulrich CM, Burt RW, Curtin K (2016 Mar). Familial Risk in Patients With Carcinoma of Unknown Primary. JAMA Oncol, 2(3), 340-6.
  22. Berndt SI, Camp NJ, Skibola CF, Vijai J, Wang Z, Gu J, Nieters A, Kelly RS, Smedby KE, Monnereau A, Cozen W, Cox A, Wang SS, Lan Q, Teras LR, Machado M, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Vajdic CM, Cocco P, Zhang Y, Giles GG, Zeleniuch-Jacquotte A, Lawrence C, Montalvan R, Burdett L, Hutchinson A, Ye Y, Call TG, Shanafelt TD, Novak AJ, Kay NE, Liebow M, Cunningham JM, Allmer C, Hjalgrim H, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M, Curtin K, Cannon-Albright LA, Diver WR, Link BK, Weiner GJ, Conde L, Bracci PM, Riby J, Arnett DK, Zhi D, Leach JM, Holly EA, Jackson RD, Tinker LF, Benavente Y, Sala N, Casabonne D, Becker N, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Chaffee KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Leis JF, Weinberg JB, Caporaso NE, Norman AD, De Roos AJ, Morton LM, Severson RK, Riboli E, Vineis P, Kaaks R, Masala G, Weiderpass E, Chirlaque MD, Vermeulen RC, Travis RC, Southey MC, Milne RL, Albanes D, Virtamo J, Weinstein S, Clavel J, Zheng T, Holford TR, Villano DJ, Maria A, Spinelli JJ, Gascoyne RD, Connors JM, Bertrand KA, Giovannucci E, Kraft P, Kricker A, Turner J, Ennas MG, Ferri GM, Miligi L, Liang L, Ma B, Huang J, Crouch S, Park JH, Chatterjee N, North KE, Snowden JA, Wright J, Fraumeni JF, Offit K, Wu X, de Sanjose S, Cerhan JR, Chanock SJ, Rothman N, Slager SL (2016). Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nat Commun, 7, 10933.
  23. Machiela MJ, Lan Q, Slager SL, Vermeulen RC, Teras LR, Camp NJ, Cerhan JR, Spinelli JJ, Wang SS, Nieters A, Vijai J, Yeager M, Wang Z, Ghesquieres H, McKay J, Conde L, de Bakker PI, Cox DG, Burdett L, Monnereau A, Flowers CR, De Roos AJ, Brooks-Wilson AR, Giles GG, Melbye M, Gu J, Jackson RD, Kane E, Purdue MP, Vajdic CM, Albanes D, Kelly RS, Zucca M, Bertrand KA, Zeleniuch-Jacquotte A, Lawrence C, Hutchinson A, Zhi D, Habermann TM, Link BK, Novak AJ, Dogan A, Asmann YW, Liebow M, Thompson CA, Ansell SM, Witzig TE, Tilly H, Haioun C, Molina TJ, Hjalgrim H, Glimelius B, Adami HO, Roos G, Bracci PM, Riby J, Smith MT, Holly EA, Cozen W, Hartge P, Morton LM, Severson RK, Tinker LF, North KE, Becker N, Benavente Y, Boffetta P, Brennan P, Foretova L, Maynadie M, Staines A, Lightfoot T, Crouch S, Smith A, Roman E, Diver WR, Offit K, Zelenetz A, Klein RJ, Villano DJ, Zheng T, Zhang Y, Holford TR, Turner J, Southey MC, Clavel J, Virtamo J, Weinstein S, Riboli E, Vineis P, Kaaks R, Boeing H, Tjonneland A, Angelucci E, Di Lollo S, Rais M, De Vivo I, Giovannucci E, Kraft P, Huang J, Ma B, Ye Y, Chiu BC, Liang L, Park JH, Chung CC, Weisenburger DD, Fraumeni JF Jr, Salles G, Glenn M, Cannon-Albright L, Curtin K, Wu X, Smedby KE, de Sanjose S, Skibola CF, Berndt SI, Birmann BM, Chanock SJ, Rothman N (2016 Apr 15). Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet, 25(8), 1663-76.
  24. Padia R, Curtin K, Peterson K, Orlandi RR, Alt J (2016 Jun). Eosinophilic esophagitis strongly linked to chronic rhinosinusitis. Laryngoscope, 126(6), 1279-83.
  25. Samadder NJ, Curtin K, Pappas L, Boucher K, Mineau GP, Smith K, Fraser A, Wan Y, Provenzale D, Kinney AY, Ulrich C, Burt RW (2016 Feb). Risk of Incident Colorectal Cancer and Death After Colonoscopy: A Population-based Study in Utah. Clin Gastroenterol Hepatol, 14(2), 279-286.e2.
  26. Orb Q, Curtin K, Oakley GM, Wong J, Meier J, Orlandi RR, Alt JA (2016 Mar). Familial risk of pediatric chronic rhinosinusitis. Laryngoscope, 126(3), 739-45.
  27. Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Ahnen D, Singh H, Ulrich CM, Burt RW, Curtin K (2015 Dec). Increased Risk of Colorectal Cancer Among Family Members of All Ages, Regardless of Age of Index Case at Diagnosis. Clin Gastroenterol Hepatol, 13(13), 2305-2311.e2.
  28. Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudzinski M, Fejerman L, Greenberg A, Huntsman S, Jamroziak K, Jurczyszyn A, Kumar S, Atanackovic D, Glenn M, Cannon-Albright LA, Jones B, Lee A, Marques H, Martin T, Martinez-Lopez J, Rajkumar V, Sainz J, Vangsted AJ, Watek M, Wolf J, Slager S, Camp NJ, Canzian F, Vachon C (2015). Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nat Commun, 6, 7539.
  29. Oakley GM, Curtin K, Orb Q, Schaefer C, Orlandi RR, Alt JA (2015 Apr). Familial risk of chronic rhinosinusitis with and without nasal polyposis: genetics or environment. Int Forum Allergy Rhinol, 5(4), 276-82.
  30. Lupo PJ, Danysh HE, Plon SE, Curtin K, Malkin D, Hettmer S, Hawkins DS, Skapek SX, Spector LG, Papworth K, Melin B, Erhardt EB, Grufferman S, Schiffman JD (2015 May). Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database. Cancer Med, 4(5), 781-90.
  31. Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR (2015 Jan 1). Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment. Drug Alcohol Depend, 146, 30-8.
  32. Samadder NJ, Smith KR, Mineau GP, Pimentel R, Wong J, Boucher K, Pappas L, Singh H, Ahnen D, Burt RW, Curtin K (2015 Mar). Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah. Aliment Pharmacol Ther, 41(6), 573-80.
  33. Venkatramani R, Spector LG, Georgieff M, Tomlinson G, Krailo M, Malogolowkin M, Kohlmann W, Curtin K, Fonstad RK, Schiffman JD (2014 Sep). Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB). Am J Med Genet A, 164A(9), 2250-5.
  34. Samadder NJ, Curtin K, Tuohy TM, Rowe KG, Mineau GP, Smith KR, Pimentel R, Wong J, Boucher K, Burt RW (2014 Oct). Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah. Gastroenterology, 147(4), 814-821.e5; quiz e15-6.
  35. Samadder NJ, Curtin K, Wong J, Tuohy TM, Mineau GP, Smith KR, Pimentel R, Pappas L, Boucher K, Garrido-Laguna I, Provenzale D, Burt RW (2014 Dec). Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah. Clin Gastroenterol Hepatol, 12(12), 2078-84.e1-2.
  36. Samadder NJ, Curtin K, Tuohy TM, Pappas L, Boucher K, Provenzale D, Rowe KG, Mineau GP, Smith K, Pimentel R, Kirchhoff AC, Burt RW (2014 Apr). Characteristics of missed or interval colorectal cancer and patient survival: a population-based study. Gastroenterology, 146(4), 950-60.
  37. Oakley GM, Curtin K, Layfield L, Jarboe E, Buchmann LO, Hunt JP (2014 May). Increased melanoma risk in individuals with papillary thyroid carcinoma. JAMA Otolaryngol Head Neck Surg, 140(5), 423-7.
  38. Kleinstein SE, Heath L, Makar KW, Poole EM, Seufert BL, Slattery ML, Xiao L, Duggan DJ, Hsu L, Curtin K, Koepl L, Muehling J, Taverna D, Caan BJ, Carlson CS, Potter JD, Ulrich CM (2013 May). Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia. Genes Chromosomes Cancer, 52(5), 437-49.
  39. Makar KW, Poole EM, Resler AJ, Seufert B, Curtin K, Kleinstein SE, Duggan D, Kulmacz RJ, Hsu L, Whitton J, Carlson CS, Rimorin CF, Caan BJ, Baron JA, Potter JD, Slattery ML, Ulrich CM (2013 Dec). COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control, 24(12), 2059-75.
  40. Abbenhardt C, Poole EM, Kulmacz RJ, Xiao L, Curtin K, Galbraith RL, Duggan D, Hsu L, Makar KW, Caan BJ, Koepl L, Owen RW, Scherer D, Carlson CS, Potter JD, Slattery ML, Ulrich CM (2013). Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia. Int J Mol Epidemiol Genet, 4(3), 140-9.
  41. Oakley GM, Curtin K, Pimentel R, Buchmann L, Hunt J (2013 Nov). Establishing a familial basis for papillary thyroid carcinoma using the Utah Population Database. JAMA Otolaryngol Head Neck Surg, 139(11), 1171-4.
  42. Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Wang SS, Kelly RS, Lan Q, Teras LR, Chatterjee N, Chung CC, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Armstrong BK, Cocco P, Zhang Y, Severi G, Zeleniuch-Jacquotte A, Lawrence C, Burdette L, Yuenger J, Hutchinson A, Jacobs KB, Call TG, Shanafelt TD, Novak AJ, Kay NE, Liebow M, Wang AH, Smedby KE, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M, Curtin K, Cannon-Albright LA, Jones B, Diver WR, Link BK, Weiner GJ, Conde L, Bracci PM, Riby J, Holly EA, Smith MT, Jackson RD, Tinker LF, Benavente Y, Becker N, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Lanasa MC, Spector LG, Leis JF, Cunningham JM, Weinberg JB, Morrison VA, Caporaso NE, Norman AD, Linet MS, De Roos AJ, Morton LM, Severson RK, Riboli E, Vineis P, Kaaks R, Trichopoulos D, Masala G, Weiderpass E, Chirlaque MD, Vermeulen RC, Travis RC, Giles GG, Albanes D, Virtamo J, Weinstein S, Clavel J, Zheng T, Holford TR, Offit K, Zelenetz A, Klein RJ, Spinelli JJ, Bertrand KA, Laden F, Giovannucci E, Kraft P, Kricker A, Turner J, Vajdic CM, Ennas MG, Ferri GM, Miligi L, Liang L, Sampson J, Crouch S, Park JH, North KE, Cox A, Snowden JA, Wright J, Carracedo A, Lopez-Otin C, Bea S, Salaverria I, Martin-Garcia D, Campo E, Fraumeni JF Jr, de Sanjose S, Hjalgrim H, Cerhan JR, Chanock SJ, Rothman N, Slager SL (2013 Aug). Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet, 45(8), 868-76.
  43. Curtin K, Smith KR, Fraser A, Pimentel R, Kohlmann W, Schiffman JD (2013 Nov 15). Familial risk of childhood cancer and tumors in the Li-Fraumeni spectrum in the Utah Population Database: implications for genetic evaluation in pediatric practice. Int J Cancer, 133(10), 2444-53.
  44. Liu AY, Scherer D, Poole E, Potter JD, Curtin K, Makar K, Slattery ML, Caan BJ, Ulrich CM (2013 Apr). Gene-diet-interactions in folate-mediated one-carbon metabolism modify colon cancer risk. Mol Nutr Food Res, 57(4), 721-34.
  45. Haug U, Poole EM, Xiao L, Curtin K, Duggan D, Hsu L, Makar KW, Peters U, Kulmacz RJ, Potter JD, Koepl L, Caan BJ, Slattery ML, Ulrich CM (2012 Jun). Glutathione peroxidase tagSNPs: associations with rectal cancer but not with colon cancer. Genes Chromosomes Cancer, 51(6), 598-605.
  46. Poole EM, Curtin K, Hsu L, Duggan DJ, Makar KW, Xiao L, Carlson CS, Caan BJ, Potter JD, Slattery ML, Ulrich CM (2012 Apr). Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancer. Cancer Epidemiol, 36(2), e104-10.
  47. Poole EM, Curtin K, Hsu L, Kulmacz RJ, Duggan DJ, Makar KW, Xiao L, Carlson CS, Slattery ML, Caan BJ, Potter JD, Ulrich CM (2011). Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer. Int J Mol Epidemiol Genet, 2(4), 300-15.
  48. Curtin K, Ulrich CM, Samowitz WS, Wolff RK, Duggan DJ, Makar KW, Caan BJ, Slattery ML (2011 Jan 1). Candidate pathway polymorphisms in one-carbon metabolism and risk of rectal tumor mutations. Int J Mol Epidemiol Genet, 2(1), 1-8.
  49. Curtin K, Slattery ML, Samowitz WS (2011). CpG island methylation in colorectal cancer: past, present and future. Patholog Res Int, 2011, 902674.
  50. Curtin K, Samowitz WS, Ulrich CM, Wolff RK, Herrick JS, Caan BJ, Slattery ML (2011). Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr Cancer, 63(3), 357-66.
  51. Slattery ML, Curtin K, Poole EM, Duggan DJ, Samowitz WS, Peters U, Caan BJ, Potter JD, Ulrich CM (2011 Jun 1). Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer, 128(11), 2726-34.
  52. Curtin K, Camp NJ (2011). Fine-scale structure of the genome and markers used in association mapping. Methods Mol Biol, 713, 71-88.
  53. Curtin K, Wolff RK, Herrick JS, Abo R, Slattery ML (2010). Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor. BMC Med Genet, 11, 170.
  54. Hutter CM, Slattery ML, Duggan DJ, Muehling J, Curtin K, Hsu L, Beresford SA, Rajkovic A, Sarto GE, Marshall JR, Hammad N, Wallace R, Makar KW, Prentice RL, Caan BJ, Potter JD, Peters U (2010). Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis. BMC Cancer, 10, 670.
  55. Slattery ML, Herrick JS, Lundgreen A, Fitzpatrick FA, Curtin K, Wolff RK (2010 Sep). Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1. Carcinog Compr Surv, 31(9), 1604-11.
  56. Slattery ML, Wolff RK, Herrick JS, Curtin K, Caan BJ, Samowitz W (2010 Aug). Alcohol consumption and rectal tumor mutations and epigenetic changes. Dis Colon Rectum, 53(8), 1182-9.
  57. Slattery ML, Herrick J, Curtin K, Samowitz W, Wolff RK, Caan BJ, Duggan D, Potter JD, Peters U (2010 Feb 15). Increased risk of colon cancer associated with a genetic polymorphism of SMAD7. Cancer Res, 70(4), 1479-85.
  58. Slattery ML, Curtin K, Wolff RK, Herrick JS, Caan BJ, Samowitz W (2010 Aug). Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes. Cancer Causes Control, 21(8), 1237-45.
  59. Campbell PT, Curtin K, Ulrich CM, Samowitz WS, Bigler J, Velicer CM, Caan B, Potter JD, Slattery ML (2009 May). Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut, 58(5), 661-7.
  60. Sweeney C, Boucher KM, Samowitz WS, Wolff RK, Albertsen H, Curtin K, Caan BJ, Slattery ML (2009 Jan). Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors. Genes Chromosomes Cancer, 48(1), 1-9.
  61. Slattery ML, Wolff RK, Curtin K, Fitzpatrick F, Herrick J, Potter JD, Caan BJ, Samowitz WS (2009 Jan 15). Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res, 660(1-2), 12-21.
  62. Curtin K, Iles MM, Camp NJ (2009 Jan). Identifying rarer genetic variants for common complex diseases: diseased versus neutral discovery panels. Ann Hum Genet, 73(1), 54-60.
  63. Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Bishop DT, Cox A, Camp NJ (2009 Feb). Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21. Cancer Epidemiol Biomarkers Prev, 18(2), 616-21.
  64. Curtin K, Samowitz WS, Wolff RK, Herrick J, Caan BJ, Slattery ML (2009 Jul 1). Somatic alterations, metabolizing genes and smoking in rectal cancer. Int J Cancer, 125(1), 158-64.
  65. Slattery ML, Curtin K, Wolff RK, Boucher KM, Sweeney C, Edwards S, Caan BJ, Samowitz W (2009 Jul). A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum, 52(7), 1304-11.
  66. Curtin K, Samowitz WS, Wolff RK, Caan BJ, Ulrich CM, Potter JD, Slattery ML (2009 Nov). MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer. Mol Carcinog, 48(11), 989-94.
  67. Samowitz WS, Curtin K, Wolff RK, Tripp SR, Caan BJ, Slattery ML (2009 Nov). Microsatellite instability and survival in rectal cancer. Cancer Causes Control, 20(9), 1763-8.
  68. Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Smith G, Bishop DT, Cox A, Camp NJ (2009 Sep). Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis. Cancer Epidemiol Biomarkers Prev, 18(9), 2476-84.
  69. Curtin K, Samowitz WS, Wolff RK, Ulrich CM, Caan BJ, Potter JD, Slattery ML (2009 Dec). Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev, 18(12), 3384-8.
  70. Slattery ML, Curtin K, Giuliano AR, Sweeney C, Baumgartner R, Edwards S, Wolff RK, Baumgartner KB, Byers T (2008 May). Active and passive smoking, IL6, ESR1, and breast cancer risk. Breast Cancer Res Treat, 109(1), 101-11.
  71. Slattery ML, Curtin K, Sweeney C, Wolff RK, Baumgartner RN, Baumgartner KB, Giuliano AR, Byers T (2008 Feb). Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk. Obesity (Silver Spring), 16(2), 339-47.
  72. Samowitz WS, Curtin K, Wolff RK, Albertsen H, Sweeney C, Caan BJ, Ulrich CM, Potter JD, Slattery ML (2008 Oct). The MLH1 -93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer. Genes Chromosomes Cancer, 47(10), 835-44.
  73. Risendal B, Hines LM, Sweeney C, Slattery ML, Giuliano AR, Baumgartner KB, Curtin K, Byers TE (2008 Dec). Family history and age at onset of breast cancer in Hispanic and non-Hispanic white women. Cancer Causes Control, 19(10), 1349-55.
  74. Wilcox MA, Li Z, Tapper W, Browning S, Curtin K, Ding J, Ding Y, Gagnon F, He Q, Kuo TY, Li M, Matthew G, Mei L, Rao S, Shaw J, Wei Z, Yu Z, Zhang W, Zheng T, Zhu G (). Genetic association with rheumatoid arthritis-Genetic Analysis Workshop 15: summary of contributions from Group 2. Genet Epidemiol, 31(Suppl 1), S12-21.
  75. Slattery ML, Curtin K, Sweeney C, Levin TR, Potter J, Wolff RK, Albertsen H, Samowitz WS (2007 Feb 1). Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer, 120(3), 656-63.
  76. Murtaugh MA, Curtin K, Sweeney C, Wolff RK, Holubkov R, Caan BJ, Slattery ML (2007 Mar). Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control, 18(2), 153-63.
  77. Curtin K, Ulrich CM, Samowitz WS, Bigler J, Caan B, Potter JD, Slattery ML (2007 May 15). Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival. Int J Cancer, 120(10), 2226-32.
  78. Slattery ML, Curtin K, Baumgartner R, Sweeney C, Byers T, Giuliano AR, Baumgartner KB, Wolff RR (2007 Apr). IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States. Cancer Epidemiol Biomarkers Prev, 16(4), 747-55.
  79. Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, Wolff RK, Albertsen H, Potter JD, Samowitz WS (2007 Aug). Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis, 28(8), 1672-9.
  80. Curtin K, Wong J, Allen-Brady K, Camp NJ (2007). PedGenie: meta genetic association testing in mixed family and case-control designs. BMC Bioinformatics, 8, 448.
  81. Curtin K, Wong J, Allen-Brady K, Camp NJ (2007). Meta-genetic association of rheumatoid arthritis and PTPN22 using PedGenie 2.1. BMC Proc, 1 Suppl 1, S12.
  82. Slattery ML, Curtin K, Wolff R, Ma KN, Sweeney C, Murtaugh M, Potter JD, Levin TR, Samowitz W (2006 Apr). PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States). Cancer Causes Control, 17(3), 239-49.
  83. Sweeney C, Curtin K, Murtaugh MA, Caan BJ, Potter JD, Slattery ML (2006 Apr). Haplotype analysis of common vitamin D receptor variants and colon and rectal cancers. Cancer Epidemiol Biomarkers Prev, 15(4), 744-9.
  84. Samowitz WS, Wolff RK, Curtin K, Sweeney C, Ma KN, Andersen K, Levin TR, Slattery ML (2006 Jul). Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Clin Gastroenterol Hepatol, 4(7), 894-901.
  85. Robien K, Curtin K, Ulrich CM, Bigler J, Samowitz W, Caan B, Potter JD, Slattery ML (2005 May). Microsomal epoxide hydrolase polymorphisms are not associated with colon cancer risk. Cancer Epidemiol Biomarkers Prev, 14(5), 1350-2.
  86. Ulrich CM, Curtin K, Samowitz W, Bigler J, Potter JD, Caan B, Slattery ML (2005 Oct). MTHFR variants reduce the risk of G:C->A:T transition mutations within the p53 tumor suppressor gene in colon tumors. J Nutr, 135(10), 2462-7.
  87. Slattery ML, Baumgartner KB, Byers T, Guiliano A, Sweeney C, Herrick J, Curtin K, Murtaugh M, Wolff R (2005 Dec). Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women. Cancer Causes Control, 16(10), 1147-57.
  88. Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML (2005 Nov). Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 14(11 Pt 1), 2509-16.
  89. Murtaugh MA, Ma KN, Benson J, Curtin K, Caan B, Slattery ML (2004 Jan 1). Antioxidants, carotenoids, and risk of rectal cancer. Am J Epidemiol, 159(1), 32-41.
  90. Slattery ML, Curtin KP, Edwards SL, Schaffer DM (2004 Feb). Plant foods, fiber, and rectal cancer. Am J Clin Nutr, 79(2), 274-81.
  91. Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM (2004 Feb). MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 13(2), 285-92.
  92. Slattery ML, Samowitz W, Curtin K, Ma KN, Hoffman M, Caan B, Neuhausen S (2004 Jul). Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers Prev, 13(7), 1206-14.
  93. Slattery ML, Neuhausen SL, Hoffman M, Caan B, Curtin K, Ma KN, Samowitz W (2004 Sep 20). Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer, 111(5), 750-6.
  94. Curtin K, Slattery ML, Holubkov R, Edwards S, Holden JA, Samowitz WS (2004 Dec). p53 alterations in colon tumors: a comparison of SSCP/sequencing and immunohistochemistry. Appl Immunohistochem Mol Morphol, 12(4), 380-6.
  95. Slattery ML, Edwards S, Curtin K, Ma K, Edwards R, Holubkov R, Schaffer D (2003 Aug 1). Physical activity and colorectal cancer. Am J Epidemiol, 158(3), 214-24.
  96. Slattery ML, Edwards S, Curtin K, Schaffer D, Neuhausen S (2003 Sep). Associations between smoking, passive smoking, GSTM-1, NAT2, and rectal cancer. Cancer Epidemiol Biomarkers Prev, 12(9), 882-9.
  97. Slattery ML, Curtin K, Schaffer D, Anderson K, Samowitz W (2002 Feb 20). Associations between family history of colorectal cancer and genetic alterations in tumors. Int J Cancer, 97(6), 823-7.
  98. Samowitz WS, Curtin K, Ma KN, Edwards S, Schaffer D, Leppert MF, Slattery ML (2002 Jun 1). Prognostic significance of p53 mutations in colon cancer at the population level. Int J Cancer, 99(4), 597-602.
  99. Slattery ML, Curtin K, Ma K, Edwards S, Schaffer D, Anderson K, Samowitz W (2002 Jun). Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev, 11(6), 541-8.
  100. Slattery ML, Curtin K, Ma K, Schaffer D, Potter J, Samowitz W (2002 Aug). GSTM-1 and NAT2 and genetic alterations in colon tumors. Cancer Causes Control, 13(6), 527-34.
  101. Samowitz WS, Curtin K, Neuhausen S, Schaffer D, Slattery ML (2002 Dec). Prognostic implications of BAX and TGFBRII mutations in colon cancers with microsatellite instability. Genes Chromosomes Cancer, 35(4), 368-71.
  102. Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, Schaffer D, Samowitz WS (2001 Jan 1). Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res, 61(1), 126-30.
  103. Samowitz WS, Holden JA, Curtin K, Edwards SL, Walker AR, Lin HA, Robertson MA, Nichols MF, Gruenthal KM, Lynch BJ, Leppert MF, Slattery ML (2001 Apr). Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol, 158(4), 1517-24.
  104. Slattery ML, Anderson K, Curtin K, Ma KN, Schaffer D, Samowitz W (2001 Aug 15). Dietary intake and microsatellite instability in colon tumors. Int J Cancer, 93(4), 601-7.
  105. Samowitz WS, Curtin K, Ma KN, Schaffer D, Coleman LW, Leppert M, Slattery ML (2001 Sep). Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev, 10(9), 917-23.
  106. Slattery ML, Anderson K, Curtin K, Ma K, Schaffer D, Edwards S, Samowitz W (2001 Nov 1). Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res, 483(1-2), 73-81.
  107. Samowitz WS, Curtin K, Lin HH, Robertson MA, Schaffer D, Nichols M, Gruenthal K, Leppert MF, Slattery ML (2001 Oct). The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology, 121(4), 830-8.
  108. Samowitz WS, Curtin K, Leppert MF, Slattery ML (2001 Dec). Uncommon TGFBRI allele is not associated with increased susceptibility to colon cancer. Genes Chromosomes Cancer, 32(4), 381-3.
  109. Slattery ML, Benson J, Curtin K, Ma KN, Schaeffer D, Potter JD (2000 Feb). Carotenoids and colon cancer. Am J Clin Nutr, 71(2), 575-82.
  110. Slattery ML, Edwards SL, Palmer L, Curtin K, Morse J, Anderson K, Samowitz W (2000 Feb). Use of archival tissue in epidemiologic studies: collection procedures and assessment of potential sources of bias. Mutat Res, 432(1-2), 7-14.
  111. Slattery ML, Curtin K, Anderson K, Ma KN, Ballard L, Edwards S, Schaffer D, Potter J, Leppert M, Samowitz WS (2000 Nov 15). Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst, 92(22), 1831-6.
  112. Samowitz WS, Curtin K, Schaffer D, Robertson M, Leppert M, Slattery ML (2000 Nov). Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol Biomarkers Prev, 9(11), 1193-7.
  113. Slattery ML, Curtin K, Anderson K, Ma KN, Edwards S, Leppert M, Potter J, Schaffer D, Samowitz WS (2000 Dec 15). Associations between dietary intake and Ki-ras mutations in colon tumors: a population-based study. Cancer Res, 60(24), 6935-41.
  114. Slattery ML, Anderson K, Samowitz W, Edwards SL, Curtin K, Caan B, Potter JD (1999 Oct). Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA). Cancer Causes Control, 10(5), 467-73.
  115. Besch BM, Curtin K, Ritch R, Allingham RR, Wrostko, BM (). Risk of indirect inguinal hernia is increased in subjects with exfoliation 1 syndrome: The Utah Project on Exfoliation Syndrome. JAMA Ophthalmol.
  116. Curtin K, Fleckenstein AE, Keeshin BR, Yurgelun-Todd DA, Renshaw PF, Smith KR, Hanson GR (). Increased Risk of Extrapyramidal Disorders in Patients with a History of Attention-Deficit/Hyperactivity Disorder. Neuropsychopharmacology.
  117. Curtin K, Theilen LH, Fraser A, Smith KR, Varner MW, Hageman GS (). Hypertensive Disease of Pregnancy Increases Risk of Neovascular Age-related Macular Degeneration. Retina.

Review

  1. Curtin K, Slattery ML, Samowitz WS (). CpG island methylation in colorectal cancer: past, present and future. [Review]. Patholog Res Int, 902674.

Book Chapter

  1. Curtin, K (). Epidemiology of colorectal adenocarcinoma. In Yantiss, RK (Eds.), Advances in surgical pathology (series). Colorectal carcinoma and tumors of the vermiform appendix (xiv 317 pages). Philadelphia: Wolters Kluwer Health/Lippincott WIlliams & Wilkins.
  2. Curtin K, Camp NJ (2009). Fine-scale structure of the genome and markers used in association mapping. In Walker JM, Teare MD (Eds.), Genetic Epidemiology, Methods in Molecular Biology (713 pt.3, pp. 71-88). New York: Humana Press.

Editorial

  1. Samadder NJ, Curtin K (2017 Apr 19). The Impact of Family History on the Risk of Colorectal Neoplasia and Screening Practices.LID - S1542-3565(17)30465-2 [pii]LID - 10.1016/j.cgh.2017.04.022 [doi]. Clin Gastroenterol Hepatol.

Abstract

  1. Wirostko B, Christiansen S, Schaumberg D, Curtin K (). High Risk Pseudoexfoliative Families Identified in the Utah Population Database [Abstract]. Investigative Ophthalmology & Visual Science (journal of the Association for Reserach in Vision and Ophthalmology), 55(13), 4283.
  2. Jasperson K, Curtin K, Burt R (). Familial Cancer Risk in Serrated Polyposis [Abstract]. InSiGHT 2013 Meeting, Cairns, Australia, August 29, 2013. Selected for oral presentation at plenary session.
  3. Curtin K, Smith KR, Fraser AM, Pimentel R, Kohlmann W, Schiffman JD (). Familial risk in pediatric cancer: implications for practice [Abstract]. American Society of Clinical Oncology (ASCO) 2012 Annual Meeting, Chicatgo Illinois, June 1-5, 2012.
  4. Samadder NJ, Tuohy T, Curtin K, Mineau G, Pimentel R, Rowe K, Burt R (). Elevated Risk of Colorectal Cancer in Relatives of Patients with Colorectal Cancer: A Population-based Study in Utah. American College of Gastroenteroogy (ACG) Colorectal Cancer Prevention Award [Abstract]. American Journal of Gastroenterology.
  5. Haug U, Poole EM, Xiao L, Slattery ML, Galbraith RL, Duggan D, Hsu Li, Makar KM, Peters U, Kulmacz RJ, Curtin K, Potter JD, Caan BJ, Koepl L, Coghill AE, Muehling J, Carson CS, Ulrich CM (). Glutathione peroxidase (GPX) candidate and tagSNPs and risk of colorectal neoplasia [Abstract]. American Association for Cancer Research, 101st Annual Meeting, Washington, DC, April 2010.
  6. Hutter CM, Chen LS, Liu Y, Slattery ML, Carlson CS, Vijayaraghavan R, Taverna D, Duggan D, Curtin K, Berndt SI, Schoen RE, Caan B, Jackson R, Kooperberg CL, LaCroix AZ, Ulrich CM, Chanock SJ, Prentice RL, Hayes RB, Potter JD, Hsu L, Peters U (). Gene-set analysis of colon cancer genome-wide association data: Identification of the TGF-beta pathway [Abstract]. American Association for Cancer Research, 101st Annual Meeting, Washington, DC, April, 2010 (poster selected for special recognition).
  7. Curtin K, Camp NJ, Lorenzo FR, Swierczek S, Prchal JT (). Investigating the genetic susceptibility of congenital polycythemia through shared genomic segment and linkage analysis in a unique extended family [Abstract]. International Genetic Epidemiology Society, 19th Annual Meeting, Boston, MA, October 2010.
  8. Koepl LM, Poole EM, Galbraith RL, Xiao L, Slattery ML, Duggan D, Kulmacz RJ, Coghill A, Hsu L, Makar KW, Curtin K, Mueling J, Taverna D, Caan BJ, Potter JD, Ulrich CM (2009). Polymorphisms in 5-lipoxygenase-activating protein and risk of colon cancer [Abstract]. American Association for Cancer Research, 100th Annual Meeting, Denver, CO, April 2009.
  9. Poole EM, Xiao L, Galbraith RL, Slattery ML, Duggan D, Kulmacz RJ, Koepl L, Coghill A, Hsu L, Makar KW, Curtin K, Mueling J, Taverna D, Caan BJ, Potter JD, Ulrich CM (2009). 15-Hydroxyprostaglandin dehydrogenase tagSNPs and risk of colon cancer [Abstract]. American Association for Cancer Research, 100th Annual Meeting, Denver, CO, April 2009.
  10. Curtin K, Cox A, Cannon-Albright LA, Camp NJ (2008). The role of disease-based discovery panels in tSNP selection [Abstract]. American Association for Cancer Research, 99th Annual Meeting, San Diego, CA, April 2008.
  11. Curtin K, Camp NJ (2007). Assessing tSNP selection: neutral versus disease-based discovery panels [Abstract]. American Society of Human Genetics, 57th Annual Meeting, San Diego, CA, October 2007.
  12. Curtin K, Wong J, Allen-Brady K, Camp NJ (2006). Meta genetic association testing in mixed family and case-control designs [Abstract]. American Society of Human Genetics, 56th Annual Meeting, New Orleans, LA, October 2006.
  13. Curtin K, Slattery ML, Sweeney C, Murtaugh M, Caan B, Ma K, Wolff R, Samowitz W (2004). VDR, calcium, and colorectal cancer [Abstract]. Society for Epidemiological Research, Salt Lake City, UT, June 2004.
  14. Ulrich CM, Curtin K, Samowitz W, Bigler J, Caan B, Potter JD, Slattery ML (2004). MTHFR variants reduce the risk of C>T transitions within the p53 tumor suppressor gene in colon tumors, but are not associated with microsatellite instability [Abstract]. American Association for Cancer Research, Frontiers in Cancer Prevention, Seattle, WA, October 2004.

Newspaper

  1. Curtin K (). Female meth users at higher risk of Parkinson’s, U. study suggests. Interview with Annie Knox, scientific reporter. The Salt Lake Tribune.
  2. Curtin, K (). Methamphetamine Use Triples Parkinson's Risk. Interview with Pauline Anderson, published in Medscape Medical News - Psychiatry. Medscape Medical News.
  3. Curtin K, Schiffman JD (). Study Showing Relatives of Pediatric Cancer Patients Have Increased Cancer Risk Points to Need for Collection of Family Medical History (reported by Heather Lindsey). Oncology Times - Vol. 35(20), pp. 32-33.

Other

  1. Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudzinski M, Fejerman L, Greenberg A, Huntsman S, Jamroziak K, Jurczyszyn A, Kumar S, Atanackovic D, Glenn M, Cannon-Albright LA, Jones B, Lee A, Marques H, Martin T, Martinez-Lopez J, Rajkumar V, Sainz J, Juul Vangsted A, Watek M, Wolf J, Slager S, Camp NJ, Canzian F, Vachon C (2015). Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nat Commun (6, p. 10203). England.
  2. Curtin, K (2008). Disease discovery panels and meta genetic association can improve detection of susceptibility loci. Ph.D. dissertation, University of Utah School of Medicine, Department of Biomedical Informatics.

Video/Film/CD/Web/Podcast

  1. Jason Hunt, Gretchen Oakley, Karen Curtin (). Your Grandmother Had Thyroid Cancer - Are You at Risk? [Video]. YouTube (Huntsman Cancer Institute). Available: https://www.youtube.com/watch?v=dvv_kwCHLs0.
  2. Curtin K, Hanson G (). Meth use increases chance of developing Parkinson’s disease, research shows [Web]. Salt Lake City: Fox13 News, Live at 4pm Interview. Available: http://fox13now.com/2014/12/16/meth-use-increases-chance-of-developing-parkinsons-disease-research-shows/.

News

Video